Sierra Capital LLC Novo Nordisk A S Transaction History

Sierra Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$102.55 - $135.33 $143,570 - $189,462	1,400 Added 8235.29%	1,417 $192,000
Q1 2022 May 03, 2022	BUY	$93.1 - $112.54 $279 - $337	3 Added 21.43%	17 $2,000
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $479 - $585	-5 Reduced 26.32%	14 $2,000
Q2 2021 Jul 22, 2021	SELL	$67.66 - $84.76 $67 - $84	-1 Reduced 5.0%	19 $2,000
Q1 2021 May 28, 2021	BUY	$67.06 - $75.82 $1,341 - $1,516	20 New	20 $1,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Sierra Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Sierra Capital LLC with notifications on news.